Karyopharm Therapeutics Inc. Accumulated Other Comprehensive Income
Karyopharm Therapeutics Inc. (KPTI) had Accumulated Other Comprehensive Income of $41.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $41.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $43.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $71.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$259.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $41.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $43.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $71.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$259.00K 10-Q · filed 2025-11-03 |
| 2025-06-30 | -$251.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$321.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$356.00K 10-K · filed 2026-02-13 |
| 2024-09-30 | -$222.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$605.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$518.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$161.00K 10-K · filed 2025-02-19 |
| 2023-09-30 | -$742.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$783.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$419.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$638.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$752.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$538.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $87.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $191.00K 10-K · filed 2023-02-17 |
| 2021-09-30 | $372.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $196.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $301.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $518.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $603.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $891.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | -$420.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | -$37.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | -$30.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $61.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$28.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$244.00K 10-K · filed 2020-02-26 |
| 2018-09-30 | -$153.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$260.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$286.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$217.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | -$90.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$165.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$204.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | -$274.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | -$28.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $138.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $94.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$282.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | -$26.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$143.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $19.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$29.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |